First Trust Indxx MeddevMDEVETF
13F holders, Q2 2026 (June 30)6holders +1
1new positions
1sold out
$19.15avg. 13F price*
At the end of Q2 2026, 6 institutions reported holding First Trust Indxx Meddev (MDEV) in their 13F filings, up 1 from Q1 2026. 1 opened new positions and 1 sold out. The largest holders were Cetera Investment Advisers ($698K), Jane Street Group, LLC ($253K) and Regatta Research & Money Management ($191K).
- Company
- First Trust Indxx Meddev
- CUSIP
- 33738R639
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $698K |
| Exits | 1 | $340K |
All 13F filers, Q1 2026 → Q2 2026: 36,496 shares bought and 36,799 shares sold, net −303 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Cetera Investment Advisers | 0.00% | New | 36,453 | $698K |
| Jane Street Group, LLC | 0.00% | Reduce -58.9% | 13,195 | $253K |
| Regatta Research & Money Management | 0.18% | — | 9,987 | $191K |
| Osaic Holdings, Inc. | 0.00% | No change | 1,106 | $21K |
| Keating Financial Advisory Services, Inc. | 0.00% | Add +13.2% | 283 | $5K |
| UBS Group AG | 0.00% | Add +111.1% | 19 | $364 |
"% of holder's portfolio" is MDEV's weight in each manager's 13F, not the share of First Trust Indxx Meddev the manager owns.